Campobello was not damaged by the Northern California fires. We are participating in helping those who have lost their homes, jobs and family members in the disasters which have decimated Sonoma County. We can immediately help those who need recovery from addictions giving them the freedom to rebuild their lives and futures.

Campobello is now fully certified and licensed to provide incidental medical services on site in our IMS room. The state of California Department of Health Care Services has done several on site inspections, reviewed staff qualifications, and other issues to standardize treatment services throughout the state. This process allows Campobello to provide care within our scope of practice, in order to give the consumers professional, competent, and appropriate services for substance use disorders. INCIDENTAL MEDICAL SERVICES (IMS) includes the following services as defined by MHSUDS Information Notice No.: 18-031:

1. Obtaining medical histories.

2. Monitoring health status to determine whether the health status warrants transfer of the client in order to receive urgent or emergent care.

3.Testing associated with detoxification from alcohol or drugs.

4. Providing alcoholism or drug abuse recovery or treatment services.

5.Over-seeing client self-administered medications.

6. Treating substance use disorders, including detoxification.

The California Department of Health Care Services are also permitting the use of what are commonly referred to as ‘replacement” or “maintenance medications” in state licensed treatment facilities like Campobello. This now referred to as “Medically Assisted Treatment”, which is not the same as Detoxification. To ensure safety and provide the highest quality of care to our clients, Campobello Chemical Dependency Recovery Center will ensure that the introduction of MAT is implemented at the appropriate time and maintained during treatment, as determined by the physician.

Examples of MAT medications include, but are not limited to, acamprosate, disulfiram, methadone, buprenorphine and naltrexone.

I